Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NuOncology Labs awarded U.S. patent for anticancer compounds

Aug. 2, 1999

Pharmacokinetic and efficacy studies reported for novel prostate cancer drug

Aug. 2, 1999

Bavarian Nordic to begin phase II study of pancreatic cancer therapy

July 30, 1999

Pilot trial commences for Eligix's BCell-HDM product

July 30, 1999

Disaccharide ester with anti-TNF-alpha effects and chemopreventive efficacy

July 29, 1999

Japanese investigators discover novel antitumor/antimicrobial agent produced by actinomycete

July 29, 1999

EntreMed cleared to begin phase I trials of Endostatin protein

July 29, 1999

Irinotecan approved as first-line treatment for advanced colorectal cancer in Europe

July 29, 1999

Approval of Busulfex injection in Canada

July 29, 1999

Abbott signs paclitaxel agreement with NaPro BioTherapeutics

July 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...